Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,189 across all filing types
Latest filing 2024-08-22 Regulatory Filings
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding an application for promoter reclassification under SEBI Listing Regulations. It mentions submission of an application for approval of reclassification of a promoter entity to public shareholding category. The content is an announcement of a regulatory action related to shareholding classification, not a financial report, earnings release, or detailed management discussion. The document length is short (1408 characters) and it is a notification to exchanges, fitting the category of a Regulatory Filing (RNS) as it does not contain financial data or detailed report content.
2024-08-22 English
Record Date
Report Publication Announcement Classification · 95% confidence The document is an official communication addressed to stock exchanges informing about the upcoming Annual General Meeting (AGM) date and the record date for dividend payment for fiscal year 2024. It mentions that the Annual Report and Notice of AGM will be shared later, indicating this document is a notification rather than the report itself. The document is short (2177 characters) and serves as an intimation or announcement rather than containing detailed AGM materials or financial data. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Report Publication Announcement (RPA). However, since it is about informing the date of AGM and dividend record date, it is best classified as a Report Publication Announcement (RPA) because it announces the upcoming AGM and dividend details but does not contain voting results or the actual AGM materials.
2024-08-22 English
Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to continuous disclosure obligations for listed companies. It announces the receipt of an Establishment Inspection Report (EIR) from the USFDA regarding the GMP status of a manufacturing facility. The document is an update or announcement about regulatory inspection results rather than a full report or detailed financial document. The length is short (1728 characters), and it serves as a regulatory announcement to stock exchanges. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-19 English
Restructuring
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the voluntary liquidation of a subsidiary, Altima Innovations, Inc. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events by listed companies. The content includes details about the liquidation, financial figures of the subsidiary, and confirms that this is an intimation under regulatory requirements. The document is relatively short (3622 characters) and serves as a disclosure notice rather than a full financial report or detailed analysis. It does not contain financial statements or detailed management discussion but is a regulatory announcement of a corporate event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-14 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the pronouncement of an order by the National Company Law Tribunal (NCLT) sanctioning a Scheme of Amalgamation involving the company and its wholly-owned subsidiary. It references a legal and corporate restructuring event rather than financial results, management changes, or shareholder votes. The document is short (1715 characters) and serves as an official announcement of a legal order related to a merger scheme. It does not contain financial statements, detailed management discussion, or voting results. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about a corporate legal event.
2024-08-14 English
Copy of Newspaper Publication
Proxy Solicitation & Information Statement Classification · 95% confidence The document contains a newspaper advertisement for meetings of equity shareholders and secured creditors pursuant to an order by the National Company Law Tribunal (NCLT) related to a Scheme of Arrangement. It references dispatch of notices for meetings, publication of advertisements, and compliance with SEBI regulations. There is no detailed financial data or full report content, but rather an announcement of meetings and related procedural information. The document is about informing shareholders and creditors about meetings and related voting matters, not the actual voting results or detailed financial statements. Therefore, it fits best as a Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is about the advertisement for meetings and not the solicitation materials themselves, and it is not the voting results, it aligns more closely with Proxy Solicitation & Information Statement (PSI) which covers materials sent to shareholders to provide information and request votes for meetings. The document is lengthy (15,000 characters) and contains detailed procedural information about the meetings, which supports PSI classification rather than a short announcement or regulatory filing. Hence, the filing type is PSI with high confidence.
2024-08-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.